Browse Data and Analysis
Filter
Search
- 12 results found
- (-) Fruits and Vegetables
- (-) Oilseeds
- (-) Western Hemisphere
- (-) Trade Policy
- Clear all
The estimated area planted to Genetically Engineered (GE) crops in Canada was down 2 percent in 2018, due primarily to lower soybean area in the prairie provinces.
U.S. exporters who want to enter or expand in India’s market have an array of opportunities available due to the country’s growing population and increasing demand for food and agricultural goods.
Costa Rican food processors and consumers trust and value food products that include U.S. raw materials and ingredients. Demand for quality ingredients has been steadily increasing...
Argentina continues to be the third largest producer of biotech crops, producing 14 percent of the world´s total biotech crops.
Negative public perceptions regarding biotechnology have influenced political will. The Mexican Supreme Court and the National Commission on Human Rights established that indigenous groups...
Honduras allows commercial production of genetically engineered (GE) crops. As of October 2016, planted GE corn areas increased by 13 percent to 38,700 hectares from the previous year.
On October 27, 2016, the Government of the Bolivarian Republic of Venezuela (GBRV) temporarily (one year) eliminated import tariffs and value added taxes for scarce agricultural products...
Central America and the Caribbean, with their close geographical and economic ties to the United States, have always been an important market for U.S. agricultural exports.
The U.S-Mexico ag trade relationship is broad and deep, with opportunities to further integrate our rural economies while supplying desired products to consumers in both countries year-round.
Although Ecuador maintains a number of anti-biotech laws and regulations, there is minimal enforcement, and trade in cotton and soybean products continues.
Honduras is the only country in Central America that allows commercial production and field trials of agricultural biotech crops.
Recent high-profile activism against biotechnology has created uncertainty among those involved in production and research of biotechnology products in Costa Rica.